Home / Resource Library / A Phase III open‑label randomized study to compare the efficacy of lenalidomide-rituximab with bendamustine rituximab in treatment‑naive follicular lymphoma
A Phase III open‑label randomized study to compare the efficacy of lenalidomide-rituximab with bendamustine rituximab in treatment‑naive follicular lymphoma